Results 181 to 190 of about 7,271 (197)

IGF2BP2 Facilitates DDP Resistance in NSCLC Through Stabilizing SEZ6L2 Expression

Journal of Biochemical and Molecular Toxicology
ABSTRACT Non‐small cell lung cancer (NSCLC) is a type of lung cancer, patients with which harbor poor overall survival. Insulin like growth factor 2 mRNA binding protein 2 (IGF2BP2) is an RNA‐binding protein, and its mechanism of action in DDP‐resistant NSCLC has not been reported.
Zhuoyu Chen, Zhaoqiang Yang, Nan Chen, Guoping Luo   +3 more
openaire   +2 more sources

The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia

Cancer Cell, 2022
Jianjun Chen, James C Mulloy, Daniel Braas   +2 more
exaly  

People also looked at

Frontiers in Molecular Biosciences, 2022
Chen Huang
exaly  

Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function

Cell Stem Cell, 2022
Ying Cheng, Pei-Pei Wang, Qing-Yong Yang
exaly  

IGF2BP2 promotes cancer progression by degrading the RNA transcript encoding a v-ATPase subunit

Proceedings of the National Academy of Sciences of the United States of America, 2022
Lu Ling, Hening Lin, Robert Samuel Weiss
exaly  

Top bar navigation

Frontiers in Oncology, 2020
Zebang Qin, Wenchuan Li
exaly  

IGF2BP2 INHIBITORS AND USES THEREOF

2021
CHEN JIANJUN, WENG HENGYOU, HUANG HUILIN, HORNE DAVID, MA YUELONG, LI HONGZHI, DENG XIAOLAN   +6 more
openaire   +2 more sources

Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway

Journal of Oral Pathology and Medicine, 2022
Shuqing Tong, Zhiming Lu, Xiaoyang Wang
exaly  

N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1

Bioengineered, 2022
Tong Li, Weiliang Song
exaly  

IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195

FEBS Letters, 2016
Liu Yang
exaly